Traverso Chambers Private Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$939K Buy
32,618
+589
+2% +$17.8K 0.23% 58
2023
Q3
$1.06M Buy
32,029
+771
+2% +$27.3K 0.28% 45
2023
Q2
$1.15M Sell
31,258
-27
-0.1% -$1.05K 0.3% 45
2023
Q1
$1.28M Buy
31,285
+752
+2% +$32.5K 0.35% 38
2022
Q4
$1.56M Sell
30,533
-164
-0.5% -$7.86K 0.45% 35
2022
Q3
$1.34M Buy
30,697
+272
+0.9% +$13.2K 0.41% 37
2022
Q2
$1.59M Buy
30,425
+464
+2% +$23.6K 0.53% 29
2022
Q1
$1.55M Sell
29,961
-465
-2% -$24.1K 0.46% 35
2021
Q4
$1.8M Buy
30,426
+469
+2% +$23.2K 0.53% 28
2021
Q3
$1.29M Sell
29,957
-5
-0% -$222 0.4% 35
2021
Q2
$1.17M Buy
29,962
+731
+3% +$28.4K 0.37% 39
2021
Q1
$1.06M Buy
29,231
+1,376
+5% +$48.9K 0.36% 38
2020
Q4
$1.02M Sell
27,855
-386
-1% -$14.2K 0.37% 36
2020
Q3
$983K Buy
28,241
+997
+4% +$35K 0.38% 33
2020
Q2
$845K Buy
27,244
+1,171
+4% +$39.8K 0.35% 36
2020
Q1
$807K Buy
26,073
+3,068
+13% +$105K 0.38% 35
2019
Q4
$855K Sell
23,005
-703
-3% -$25K 0.36% 38
2019
Q3
$808K Sell
23,708
-141
-0.6% -$5.13K 0.39% 37
2019
Q2
$1M Hold
23,849
0.49% 34
2019
Q1
$961K Sell
23,849
-79
-0.3% -$3.16K 0.47% 33
2018
Q4
$991K Buy
+23,928
New +$993K 0.54% 30

Other funds holding PFE

Traverso Chambers Private Wealth Management's PFE Position: Q4 2023 in Review

Traverso Chambers Private Wealth Management increased its Pfizer (PFE) stake by 1.8% in Q4 2023, buying an estimated $17.8K and bringing the position to 32,618 shares worth $939K. The position accounts for 0.23% of the portfolio, ranked #58.

Traverso Chambers Private Wealth Management first reported a position in PFE in Q4 2018 and has held it in 21 quarters since. The position peaked at $1.8M in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Traverso Chambers Private Wealth Management held 32,618 shares of Pfizer worth $939K as of Q4 2023.
  • Traverso Chambers Private Wealth Management bought 589 Pfizer shares in Q4 2023, an estimated $17.8K.
  • Pfizer made up 0.23% of Traverso Chambers Private Wealth Management's portfolio in Q4 2023, its #58 holding.
  • Traverso Chambers Private Wealth Management first reported a position in Pfizer in Q4 2018 and has held it in 21 quarters since.
  • Traverso Chambers Private Wealth Management's Pfizer position peaked at $1.8M in Q4 2021.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Traverso Chambers Private Wealth Management's 13F filing for Q4 2023, filed 9 Jan 2024.